About OPTIMVIA, LLC
Optimvia is a biopharmaceutical company specializing in engineering enzymes and their cofactors to synthesize complex therapeutic molecules, with a focus on developing biosynthetic heparin using its ADEPT® platform.
Engineering enzymes and cofactors for therapeutic molecule synthesisDevelopment of biosynthetic heparin using the ADEPT® platformCreation of new proteins with tailored functions for therapeutic useImproving the economics and scalability of synthetic heparin production
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to OPTIMVIA, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.